Literature DB >> 10178185

User fees, self-selection and the poor in Bangladesh.

S Thomas1, J R Killingsworth, S Acharya.   

Abstract

The widespread uncontrolled introduction of user fees in any developing country is likely to have a disastrous impact on poorer patients. Furthermore, traditional targeting schemes aimed at their exemption are often expensive, difficult to administer and ineffective at reaching those in greatest need. This research study examines how user fees can raise revenue and target poorer patients, under the right market conditions, without resorting to costly targeting schemes. The authors draw their findings from case studies of cost recovery in the health and population sectors in Bangladesh. The mechanism suggested in the paper is to use self-selection. It is argued that under certain market conditions poorer patients will choose the health-care option that is appropriate to their means. They will thus identify themselves as poor without having to be selected or tested by an independent authority. This self-selection allows the relevant authorities to cross-subsidize their market choice by over-charging the non-poor in other segments of the market.

Entities:  

Mesh:

Year:  1998        PMID: 10178185     DOI: 10.1093/heapol/13.1.50

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  3 in total

1.  Getting women to hospital is not enough: a qualitative study of access to emergency obstetric care in Bangladesh.

Authors:  E Pitchforth; E van Teijlingen; W Graham; M Dixon-Woods; M Chowdhury
Journal:  Qual Saf Health Care       Date:  2006-06

2.  Correction of refractive error and presbyopia in Timor-Leste.

Authors:  J Ramke; R du Toit; A Palagyi; G Brian; T Naduvilath
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

3.  Coping strategies for financial burdens in families with childhood pneumonia in Bangladesh.

Authors:  Nadia I Alamgir; Aliya Naheed; Stephen P Luby
Journal:  BMC Public Health       Date:  2010-10-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.